{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:37:55Z","timestamp":1761395875207,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"QIAGEN QSI"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jcv.2020.104681","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T23:46:24Z","timestamp":1604101584000},"page":"104681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["First performance report of QIAreach\u2122 Anti-SARS-CoV-2 Total Test, an innovative nanoparticle fluorescence digital detection platform"],"prefix":"10.1016","volume":"133","author":[{"given":"Francis","family":"Stieber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia N.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Masae","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Manissero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Love","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harmony","family":"Douwes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Fairburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jcv.2020.104681_bib0005","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2020.104681_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2020.07.011","article-title":"The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review of the current global status","author":"Bchetnia","year":"2020","journal-title":"J Infect Public Health"},{"issue":"9","key":"10.1016\/j.jcv.2020.104681_bib0015","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1016\/S1473-3099(20)30517-X","article-title":"Serology testing in the COVID-19 pandemic response","volume":"20","author":"Peeling","year":"2020","journal-title":"Lancet Infect. Dis."},{"volume":"18","year":"2020","author":"European Commission","key":"10.1016\/j.jcv.2020.104681_bib0020"},{"volume":"1","year":"2020","author":"European Centre for Disease Prevention and Control","key":"10.1016\/j.jcv.2020.104681_bib0025"},{"key":"10.1016\/j.jcv.2020.104681_bib0030","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019","author":"Zhao","year":"2020","journal-title":"Clinical Infect Dis"},{"issue":"2","key":"10.1016\/j.jcv.2020.104681_bib0035","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01526-2020","article-title":"Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients","volume":"56","author":"Yu","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jcv.2020.104681_bib0040","article-title":"Dynamics and significance of the antibody response to SARS-CoV-2 infection","author":"Iyer","year":"2020","journal-title":"medRxiv"},{"issue":"2","key":"10.1016\/j.jcv.2020.104681_bib0045","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00763-2020","article-title":"Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset","volume":"56","author":"Lou","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jcv.2020.104681_bib0050","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41423-020-0474-z","article-title":"Serum IgA, IgM, and IgG responses in COVID-19","volume":"17","author":"Ma","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jcv.2020.104681_bib0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cca.2020.04.026","article-title":"IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: a longitudinal study","volume":"507","author":"Padoan","year":"2020","journal-title":"Clinical Chimica Acta"},{"key":"10.1016\/j.jcv.2020.104681_bib0060","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa463","article-title":"Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections","author":"Rijkers","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2020.104681_bib0065","article-title":"Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice","author":"Long","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.jcv.2020.104681_bib0070","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138759","article-title":"Kinetics of viral load and antibody response in relation to COVID-19 severity","author":"Wang","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcv.2020.104681_bib0075","article-title":"Viral kinetics and antibody responses in patients with COVID-19","author":"Tan","year":"2020","journal-title":"medRxiv."},{"year":"2020","author":"US Food and Drug Administration","series-title":"Important Information on the Use of Serological (Antibody) Tests for COVID-19 - Letter to Health Care Providers","key":"10.1016\/j.jcv.2020.104681_bib0080"},{"year":"2020","author":"Infectious Diseases Society of America","series-title":"IDSA COVID-19 Antibody Testing Primer. IDSA","key":"10.1016\/j.jcv.2020.104681_bib0085"},{"issue":"10230","key":"10.1016\/j.jcv.2020.104681_bib0090","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(20)30788-1","article-title":"Developing antibody tests for SARS-CoV-2","volume":"395","author":"Petherick","year":"2020","journal-title":"Lancet"},{"author":"CDC","key":"10.1016\/j.jcv.2020.104681_bib0095"},{"issue":"1","key":"10.1016\/j.jcv.2020.104681_bib0100","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/EBC20150012","article-title":"Lateral flow assays","volume":"60","author":"Koczula","year":"2016","journal-title":"Essays Biochem."},{"year":"2020","author":"US Food and Drug Administration","series-title":"Certain COVID-19 Serology\/Antibody Tests Should Not Be Used - Letter to Clinical Laboratory Staff and Health Care Providers","key":"10.1016\/j.jcv.2020.104681_bib0105"},{"key":"10.1016\/j.jcv.2020.104681_bib0110","doi-asserted-by":"crossref","first-page":"m2516","DOI":"10.1136\/bmj.m2516","article-title":"Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis","volume":"370","author":"Bastos","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jcv.2020.104681_bib0115","article-title":"Test performance evaluation of SARS-CoV-2 serological assays","author":"Whitman","year":"2020","journal-title":"medRxiv"},{"issue":"2","key":"10.1016\/j.jcv.2020.104681_bib0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jama.2020.11160","article-title":"Hospital-wide SARS-CoV-2 antibody screening in 3056 staff in a tertiary center in Belgium","volume":"324","author":"Steensels","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jcv.2020.104681_bib0125","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/CVI.00211-16","article-title":"Immunoglobulin M for acute infection: true or false?","volume":"23","author":"Landry","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"year":"2020","author":"US Food and Drug Administration","series-title":"EUA Authorized Serology Test Performance","key":"10.1016\/j.jcv.2020.104681_bib0130"},{"year":"2020","author":"US Food and Drug Administration","series-title":"In Vitro Diagnostics EUAs","key":"10.1016\/j.jcv.2020.104681_bib0135"},{"issue":"3","key":"10.1016\/j.jcv.2020.104681_bib0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/labmed\/lmaa025","article-title":"Double-edged spike-are SARS-CoV-2 serologic tests safe right now?","volume":"51","author":"Torres","year":"2020","journal-title":"Lab. Med."},{"key":"10.1016\/j.jcv.2020.104681_bib0145","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01361-20","article-title":"Evaluation of six commercial mid to high volume antibody and six point of care lateral flow assays for detection of SARS-CoV-2 antibodies","author":"Charlton","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2020.104681_bib0150","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa467","article-title":"Evaluation of serological tests for SARS-CoV-2: implications for serology testing in a low-prevalence setting","author":"Bond","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2020.104681_bib0155","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2020-215732","article-title":"Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey","author":"Flower","year":"2020","journal-title":"Thorax"},{"author":"Hanson","key":"10.1016\/j.jcv.2020.104681_bib0160"},{"key":"10.1016\/j.jcv.2020.104681_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104569","article-title":"Comparison of different serological assays for SARS-CoV-2 in real life","volume":"130","author":"Brochot","year":"2020","journal-title":"J. Clin. Virol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653220304236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653220304236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:12:50Z","timestamp":1761361970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653220304236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":33,"alternative-id":["S1386653220304236"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104681","relation":{},"ISSN":["1386-6532"],"issn-type":[{"type":"print","value":"1386-6532"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First performance report of QIAreach\u2122 Anti-SARS-CoV-2 Total Test, an innovative nanoparticle fluorescence digital detection platform","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104681"}}